HSBC Holdings’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Buy
59,466
+20,076
+51% +$97.1K ﹤0.01% 2635
2026
Q1
$210K Buy
+39,390
New +$243K ﹤0.01% 2592
2023
Q2
Sell
-3,728
Closed -$18.2K 2766
2023
Q1
$18.2K Hold
3,728
﹤0.01% 2612
2022
Q4
$15.9K Sell
3,728
-40
-1% -$196 ﹤0.01% 3023
2022
Q3
$40K Sell
3,768
-63
-2% -$879 ﹤0.01% 2840
2022
Q2
$54K Hold
3,831
﹤0.01% 3130
2022
Q1
$66K Buy
+3,831
New +$66K ﹤0.01% 3175

Other funds holding VSTM

HSBC Holdings's VSTM Position: Q2 2026 in Review

HSBC Holdings increased its Verastem (VSTM) stake by 51% in Q2 2026, buying an estimated $97.1K and bringing the position to 59,466 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

HSBC Holdings first reported a position in VSTM in Q1 2022 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • HSBC Holdings held 59,466 shares of Verastem worth $232K as of Q2 2026.
  • HSBC Holdings bought 20,076 Verastem shares in Q2 2026, an estimated $97.1K.
  • Verastem made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2635 holding.
  • HSBC Holdings first reported a position in Verastem in Q1 2022 and has held it in 7 quarters since.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.